Skip to product information
1 of 1

Elabscience

SKU:E-AB-13839

TLR8 Polyclonal Antibody

TLR8 Polyclonal Antibody

Regular price $420.00 USD
Regular price Sale price $420.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

TLR8 Polyclonal Antibody

The TLR8 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of Toll-like receptor 8 (TLR8) protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human TLR8 protein. The resulting polyclonal antibody has been purified using protein A affinity chromatography and validated for its specificity and sensitivity by various immunoassays, including Western blotting, immunohistochemistry, and ELISA.

The TLR8 Polyclonal Antibody is a valuable tool for researchers studying the role of TLR8 in innate immunity, inflammation, and cancer. It can be used to detect TLR8 expression in various cell types and tissues, including human peripheral blood mononuclear cells (PBMCs), dendritic cells, macrophages, and epithelial cells. This antibody can also be used for functional studies, such as blocking TLR8 signaling or activating TLR8-mediated immune responses.

The TLR8 Polyclonal Antibody is supplied as a liquid formulation in phosphate-buffered saline (PBS) with 0.02% sodium azide as a preservative. It is available in various sizes and formats, including 50 µg, 100 µg, and 500 µg vials, as well as conjugated forms with different labels, such as FITC, PE, APC, and biotin. This antibody is recommended for use in research applications only and should not be used for diagnostic or therapeutic purposes.

In summary, the TLR8 Polyclonal Antibody is a high-quality and reliable reagent that can facilitate the investigation of TLR8 biology and function in various experimental settings. Its specificity, sensitivity, and versatility make it an essential tool for immunologists, cell biologists, and cancer researchers.

View full details